Obesity Drug Sales Forecasts – Why They Are Out of Whack
How many times now have we heard about the next new anti-obesity drug blockbuster, that never met expectations? The next multi-billion dollar/year magic pill? Qnexa by Vivus is the latest to get a nod from an FDA review panel. Soon we’ll be hearing the Wall Street analysts proclaim Qnexa’s virtues, the growing global obesity problem […]
Obesity Drug Sales Forecasts – Why They Are Out of Whack Read More »